Torrent Pharmaceuticals (TORNTPHARM) Share Price falls 2.01% today
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Torrent Pharmaceuticals Share Price declined to Rs 4,885 today, down 2.01% from the previous close of Rs 4,985. The company’s market capitalisation stands at Rs 1,89,613.38 crore, placing Torrent Pharmaceuticals in the Large Cap category. In today’s trade, the stock opened at Rs 4,988.50, touched a high of Rs 4,990 and a low of Rs 4,885, and ended at the day’s low. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Torrent Pharmaceuticals Share Price Today, the move is relevant because the stock is still priced at a premium to the sector benchmark and to several peers, even after the decline. Univest is covering the stock’s price action, fundamentals and industry context in a single note.
Torrent Pharmaceuticals (TORNTPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,885 |
| Previous Close | Rs 4,985 |
| Today's Move | -Rs 100.00 (-2.01%) |
| Open | Rs 4,988.5 |
| High | Rs 4,990 |
| Low | Rs 4,885 |
| Turnover | Rs 0.7 crore |
| Market Capitalisation | Rs 1,89,613.38 crore |
| Market Cap Category | Large Cap |
Torrent Pharmaceuticals Share Price Today closed at Rs 4,885 after falling Rs 100 in absolute terms and 2.01% in percentage terms. The session began at Rs 4,988.50, almost in line with the previous close of Rs 4,985, and the stock briefly printed a day high of Rs 4,990 before moving lower to the day low of Rs 4,885. That means the final close matched the lowest point of the day. The reported turnover was Rs 0.70 crore. With a market capitalisation of Rs 1,89,613.38 crore, Torrent Pharmaceuticals remains a Large Cap name, and that scale should be read as company-size context only. The price action today shows a clear downward session, but the supplied data does not assign a reason for the move. For investors following Torrent Pharmaceuticals Share Price and Torrent Pharmaceuticals Stock News, the next step is to compare the day’s move with the company’s valuation and sector positioning.
Torrent Pharmaceuticals (TORNTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,89,613.38 crore |
| P/E Ratio | 86.94x |
| P/B Ratio | 21.13x |
| ROE | 26.76% |
| ROCE | 19.27% |
| EPS | Rs 57.34 |
| Book Value Per Share | Rs 235.97 |
| Dividend Yield | 0.76% |
Torrent Pharmaceuticals Share Price sits alongside a market capitalisation of Rs 1,89,613.38 crore, a P/E ratio of 86.94 and a P/B ratio of 21.13. Those are the key valuation markers in the supplied set, and they place Torrent Pharmaceuticals at a meaningfully higher valuation than the healthcare industry benchmark shown later in this note. The company reports ROE of 26.76% and ROCE of 19.27%, which indicate strong return metrics in absolute terms. EPS stands at Rs 57.34, book value at Rs 235.97 and dividend yield at 0.76%, so the current share price is trading at a substantial multiple to accounting book value and earnings. Univest flags these figures because Torrent Pharmaceuticals Share Price is not only a price-action story; it is also a valuation story. For readers looking up Torrent Pharmaceuticals Fundamental Analysis, the numbers suggest the stock is priced with elevated expectations, while the latest decline has not changed the underlying profitability ratios reported here.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 86.94x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 49.63x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 21.13x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.33x |
| Company ROE | 26.76% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10.04% |
| Company ROCE | 19.27% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.82% |
| Company Market Capitalisation | Rs 1,89,613.38 crore |
| Benchmark Median Market Cap | Rs 732.57 crore |
| Benchmark Average Market Cap | Rs 14,043.26 crore |
Torrent Pharmaceuticals operates in Healthcare within Pharmaceuticals & Drugs, and the relevant benchmark scope is the same industry with 204 companies. Against that benchmark, the company’s P/E of 86.94 is above the industry median of 32.87 and above the industry average of 49.63. Its P/B of 21.13 is also above the sector median of 2.85 and the sector average of 4.33. On profitability, Torrent Pharmaceuticals reports ROE of 26.76%, higher than the industry median of 11.48% and the average of 10.04%, while ROCE of 19.27% is above the industry median of 13.17% and average of 12.82%. In the same benchmark set, market cap medians and averages are much lower than Torrent Pharmaceuticals’ Rs 1,89,613.38 crore market value. This is why Torrent Pharmaceuticals Share Price is often read through both a quality lens and a valuation lens. Univest’s sector view shows a company with stronger returns than the industry median, but also a richer valuation than most peers in the benchmark sample.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 87.22 | 14.44 | 16.19 | 21.51 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.57 | 4.45 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
| Laurus Labs | LAURUSLABS | 1,08,116.47 | 98.88 | 19.17 | 18.31 | 18.2 |
Peer data places Torrent Pharmaceuticals Share Price in the company of other large healthcare names, but the valuation and profitability profile is mixed versus listed peers. Sun Pharmaceutical Industries has a lower P/E of 36.77 and P/B of 5.14, while Divi’s Laboratories shows a P/E of 87.22 and P/B of 14.44. Zydus Lifesciences trades at a P/E of 26.57 and P/B of 4.45, Cipla at 33.49 and 3.21, and Laurus Labs at 98.88 and 19.17. On return ratios, Torrent Pharmaceuticals’ ROE of 26.76% is above the peer values shown for Sun Pharma, Divi’s, Zydus, Cipla and Laurus Labs in this set, and its ROCE of 19.27% is also competitive, though some peers such as Divi’s and Zydus show higher ROCE. The stock’s market cap of Rs 1,89,613.38 crore is below Sun Pharma’s but above several peers in the list.
Why Investors Are Watching Torrent Pharmaceuticals
- Torrent Pharmaceuticals Share Price fell 2.01% today to Rs 4,885 from Rs 4,985.
- The stock opened at Rs 4,988.50, touched Rs 4,990 and finished at the day low of Rs 4,885.
- Turnover was Rs 0.70 crore in today’s session.
- P/E is 86.94 and P/B is 21.13, both above the sector benchmark median.
- ROE is 26.76% and ROCE is 19.27%, which remain above the industry median in the supplied benchmark set.
About Torrent Pharmaceuticals
Torrent Pharmaceuticals is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data in this note focuses on market price, valuation, profitability and benchmark context rather than a detailed business breakdown. For readers researching Torrent Pharmaceuticals Share Price, the most relevant company facts here are its Large Cap market status, Rs 1,89,613.38 crore market capitalisation, Rs 57.34 EPS, Rs 235.97 book value and 0.76% dividend yield. Univest is using only verified figures in this article, so the narrative stays tied to the published numbers and the stock’s current market context.
Track Torrent Pharmaceuticals Share Price on Univest
Use Torrent Pharmaceuticals (TORNTPHARM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Torrent Pharmaceuticals Share Price on Univest for live price updates, valuation ratios, market capitalisation, sector context and peer comparison. Univest also organises the stock’s shareholding pattern, 52-week levels, financial ratios and market insights in one place for easier monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Torrent Pharmaceuticals Share Price falling today?
Ans. Torrent Pharmaceuticals Share Price fell 2.01% to Rs 4,885, but the supplied data does not establish a company-specific catalyst. The session opened near the previous close and ended at the day low.
What is Torrent Pharmaceuticals Share Price today?
Ans. Torrent Pharmaceuticals Share Price today is Rs 4,885. It is down Rs 100 from the previous close of Rs 4,985, with the stock ending the session at its day low.
What does Torrent Pharmaceuticals Share Price show about valuation?
Ans. Torrent Pharmaceuticals Share Price trades with a P/E of 86.94 and a P/B of 21.13. Both are above the industry benchmark median, which indicates a richer valuation versus the supplied sector set.
How does Torrent Pharmaceuticals compare with healthcare peers?
Ans. Torrent Pharmaceuticals has a market cap of Rs 1,89,613.38 crore. Its ROE of 26.76% is above several listed peers in the supplied set, while its P/E is higher than most of them.
What are the key financial metrics for Torrent Pharmaceuticals Share Price?
Ans. Key metrics include EPS of Rs 57.34, book value of Rs 235.97, dividend yield of 0.76%, ROE of 26.76% and ROCE of 19.27%. These figures add context to Torrent Pharmaceuticals Share Price.
